Skip to main content
SpringerLink
Log in

The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Disopyramide exhibits saturable binding to plasma proteins in the therapeutic plasma concentration range. Because of this property, controversy exists in the literature regarding the pharmacokinetic properties of the drug. The purposes of this study were to reassess the pharmacokinetic properties of disopyramide in humans, taking into consideration both total and unbound concentrations and to use disopyramide as a model compound to study the effect of drug binding on the renal clearance of both total and unbound drug. A single intravenous dose of disopyramide (1.5 mg/kg) was administered to eight normal volunteers. Blood and urine samples were collected for 36h. Total concentrations of disopyramide in plasma and urine were determined by high pressure liquid chromatography. Binding of disopyramide to plasma proteins was determined by equilibrium dialysis. In all subjects, the binding of disopyramide to plasma proteins was saturable, but there were considerable differences in binding between subjects. The volume of distribution, total body clearance, and renal clearances of both total and unbound drug were calculated. Because only the total body clearance and renal clearance of unbound compound are not dependent upon unbound fraction (α), these are the only parameters which can be reported without qualification as to the concentration. The mean ± SD total body clearance of unbound drug in the eight subjects was 5.40± 2.80 ml/min/kg. About 50% of this was due to renal elimination. A statistically significant negative correlation of the renal clearance of total disopyramide with time was observed in seven of eight subjects, whereas a significant correlation between the renal clearance of unbound disopyramide and time was observed in only one subject. This suggests that the renal clearance of unbound disopyramide is independent of α, while the renal clearance of total disopyramide is dependent upon α.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A. Karim, C. Cook, R. L. Novotney, J. Zagarella, and J. Campion. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.Drug Metab Dispos. 6:338–345 (1978).

    CAS  PubMed  Google Scholar 

  2. A. Karim, R. E. Ranney, and S. Kraychy. Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate.J. Pharm. Sci. 61:888–893 (1972).

    Article  CAS  PubMed  Google Scholar 

  3. R. E. Ranney, R. R. Dean, A. Karim, and F. M. Radzialowski. Disopyramide phosphate: pharmacokinetics and pharmacologic relationships of a new antiarrhythmic agent.Arch. Int. Phamacodyn. 191:162–188 (1971).

    CAS  Google Scholar 

  4. A. Karim. The pharmacokinetics of Norpace.Angiology 264 (Suppl. 2, part 1): 85–98 (1975).

    Google Scholar 

  5. W. S. Hillis, A. Tweddel, A. R. Lorimer, and T. D. V. Lawrie. Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction.J. Intern. Med. Res. 4 (Suppl. 1):74–77 (1976).

    CAS  Google Scholar 

  6. J. W. Ward and G. R. Kinghorn. The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimen.J. Intern. Med. Res. 4 (Suppl.1):49–53 (1976).

    CAS  Google Scholar 

  7. S. M. Bryson, B. Whiting, and J. R. Lawrence. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.Br. J. Clin. Pharmacol. 6:409–419 (1978).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. J. R. Lawrence, S. M. Bryson, D. J. Sumner, B. C. Campbell, and B. Whiting. The renal clearance of disopyramide after bolus intravenous injecton.Biopharm. Drug. Dispos. 1:51–57 (1979).

    Article  CAS  PubMed  Google Scholar 

  9. P. H. Hinderung, J. Bres, and E. R. Garrett. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.J. Pharm. Sci. 63:1684–1690 (1974).

    Article  Google Scholar 

  10. P. J. Meffin, E. W. Robert, R. A. Winkle, S. Harapat, F. A. Peters, and D. C. Harrison. The role of concentration-dependent plasma protein binding in disopyramide disposition.J. Pharmacokin. Biopharm. 7:29–46 (1979).

    Article  CAS  Google Scholar 

  11. P. H. Hinderling and E. R. Garrett. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.J. Pharmacokin. Biopharm. 4:199–230 (1976).

    Article  CAS  Google Scholar 

  12. J. L. Cunningham, D. D. Shen, I. Shudo, and D. L. Azarnoff. The effect of urine pH and plasma protein binding on the renal clearance of disopyramide.Clin. Pharmacokin. 2:373–383 (1977).

    Article  CAS  Google Scholar 

  13. K. M. Giacomini, A. Abang, and T. F. Blaschke. Calculations of drug concentrations in plasma after equilibrium dialysis.J. Pharm. Sci. (submitted for publication).

  14. G. Levy. Effect of plasma protein binding on renal clearance of drugs.J. Pharm. Sci. 69:482–483 (1980).

    Article  CAS  PubMed  Google Scholar 

  15. P. J. Meffin, S. R. Harapat, and D. C. Harrison. High-pressure liquid Chromatographic analysis of drugs in biological fluids. III. Analysis of disopyramide and its mono-N-dealkylated metabolite in plasma and urine.J. Chromatogr. 132:503–510 (1977).

    Article  CAS  PubMed  Google Scholar 

  16. K. F. Ilett, I. P. Hackett, L. J. Dusci, and R. Tjokrosetio. Assay of disopyramide by high pressure liquid chromatography.J. Chromatogr. 154:325–329 (1978).

    Article  CAS  PubMed  Google Scholar 

  17. E. K. Chung.Electrocardiography, Harper & Row, Hagerstown, Md., 1974, p. 45.

    Google Scholar 

  18. G. D. Knott and D. K. Reece. MLAB: a civilized curve fitting system. InProceedings of the Online 1972 International Conference, Brunei University, Uxbridge, England, Vol. 1, pp. 497–526.

  19. L. Z. Benet and R. L. Galeazzi. Non-compartmental determination of the steady state volume of distribution.J. Pharm. Sci. 68:1071–1074 (1979).

    Article  CAS  PubMed  Google Scholar 

  20. S. Oie, T. W. Guentert, and T. N. Tozer. Effect of saturable binding on the pharmacokinetics of drugs: a simulation.J. Pharm. Pharmacol. 32:471–477 (1979).

    Article  Google Scholar 

  21. K. M. Giacomini, J. C. Giacomini, S. E. Swezey, and T. F. Blaschke. Stereoselective disposition of disopyramide in the dog.J. Cardiovasc. Pharmacol. 2:825–832 (1980).

    Article  CAS  PubMed  Google Scholar 

  22. B. Whiting, N. H. G. Holford, and L. B. Sheiner. Quantitative analysis of the disopyramide concentration-effect relationship.Br. J. Clin. Pharmacol. 9:67–75 (1980).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. G. J. Davies, P. K. Marrott, and J. R. Muir. Haemodynamic and electrocardiographic effects of intravenous disopyramide (Rythmodan) following acute myocardial infarction.Br. J. Clin. Pharmacol. 7:183–187 (1979).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Kathleen M. Giacomini

    Present address: Department of Pharmacy, School of Pharmacy, University of California, 94143, San Francisco, California

Authors and Affiliations

  1. Division of Clinical Pharmacology, Department of Medicine, Stanford University Medical Center, Stanford, California

    Kathleen M. Giacomini, Sarah E. Swezey, Kathleen Turner-Tamiyasu & Terrence F. Blaschke

Authors
  1. Kathleen M. Giacomini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah E. Swezey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kathleen Turner-Tamiyasu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Terrence F. Blaschke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giacomini, K.M., Swezey, S.E., Turner-Tamiyasu, K. et al. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide. Journal of Pharmacokinetics and Biopharmaceutics 10, 1–14 (1982). https://doi.org/10.1007/BF01059180

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01059180

Key words

Search

Navigation